Review of Acomplia

Pros:

Acomplia has been used to help those who are trying to quit smoking.

Cons:

Negative side effects like: sleeping disorders, depression, diarrhea, excessive sweating

Rating:

Verdict:

Acomplia is a drug for losing weight that is designed to help individuals that are struggling with obesity. This drug is the first in a new kind of class for weight loss that is called ‘Cannabinoid-1 Receptor Blockers’, better known as CB1. Acomplia basically blocks receptors in your brain so that it can control cravings and decrease your appetite, but only when it is taken as your doctor directs. With this support, people are able to more effectively lose weight.

How Acomplia Works

Because Acomplia is put in the ‘Cannabinoid-1 Receptor Blocker’ classification, it works by blocking CB1 receptors of the brain and of peripheral organs selectively. When these receptors have been blocked, Acomplia works to actively decrease the over-activity of systems in the body that control metabolism, weight, energy balance, and fat storage. Most users of Acomplia experience great weight loss in only the first nine months, while most consumers have reported that the loss of weight was maintained stable for two years following taking the supplement.

Who Can Take Acomplia?

People who are interest in using Acomplia have to meet with their doctor first, because this weight loss supplement is only available through a prescription. In order to get approval for Acomplia, you have to rate more than 30 on the Body Mass Index. While this weight loss drug is mainly intended to aid individuals with losing weight, Acomplia has been used to treat other conditions as well, which include:
The prevention of cardiovascular disease
To help those who have a very big waist circumference
Abnormal fat levels in the blood
Type 2 Diabetes

Smoking and Acomplia

Along with providing individuals with the benefits of losing weight, Acomplia has been used to help those who are trying to quit smoking as well. A study of Acomplia done over a one-year period showed that more than 6,500 people could stop smoking while using this drug.

Detriments of Acomplia

While the European Union approved Acomplia in 2006, the Food and Drug Administration of the United States hasn’t approved this drug yet. Also, some of its users have reported experiencing some negative side effects like:
Infection in the upper respiratory tract
Sleeping disorders
Depression
Diarrhea
Excessive Sweating
Fatigue
Back Pain
Vomiting and nausea
Upset stomach
Nervousness
Dizziness
Itching
Muscle cramps
Bruising and tendinitis
Hot flashes and memory loss

Trials and Clinical Studies of Acomplia

Clinical studies and trials have been done on more than 6,800 Acomplia consumers. All members of the trials were considered overweight or obese, and they also suffered from other conditions, like dyslipidaemia or hypertension. In these studies, about 80% were women, and the rest were men. During the year, the average consumer of Acomplia lost about 14.5 pounds in comparison to individuals who lost only about 3.5 pounds using a placebo.